Skip to main content

Cumberland Pharmaceuticals, Inc. (CPIX)

NASDAQ: CPIX · IEX Real-Time Price · USD
2.70
+0.02 (0.75%)
After-hours:Oct 22, 2021 5:55 PM EDT
2.68
0.01 (0.37%)
At close: Oct 22, 4:00 PM
Market Cap39.88M
Revenue (ttm)39.10M
Net Income (ttm)29,876
Shares Out14.98M
EPS (ttm)0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,102
Open2.68
Previous Close2.67
Day's Range2.62 - 2.68
52-Week Range2.58 - 3.94
Beta0.24
AnalystsStrong Buy
Price Target8.50 (+217.2%)
Est. Earnings DateNov 9, 2021

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylo...

IndustryPharmaceuticals
IPO DateAug 11, 2009
Employees90
Stock ExchangeNASDAQ
Ticker SymbolCPIX
Full Company Profile

Financial Performance

In 2020, CPIX's revenue was $37.44 million, an increase of 8.88% compared to the previous year's $34.39 million. Losses were -$3.34 million, -5.61% less than in 2019.

Financial Statements

Analyst Forecast

According to one analyst, the rating for CPIX stock is "Strong Buy" and the 12-month stock price forecast is 8.50.

Price Target
$8.50
(217.16% upside)
Analyst Consensus: Strong Buy

News

Cumberland Pharmaceuticals Launches RediTrex® Product Line For Active Rheumatoid, Juvenile Idiopathic And Severe Psor...

NASHVILLE, Tenn., Sept. 29, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today the national launch of its RediTrex ® (methotrexate) ...

3 weeks ago - PRNewsWire

Cumberland Pharmaceuticals (CPIX) Reports Break-Even Earnings for Q2

Cumberland (CPIX) delivered earnings and revenue surprises of 100.00% and 5.66%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update

NASHVILLE, Tenn., Aug. 10, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and second quarter 2021 financial ...

2 months ago - PRNewsWire

Earnings Preview: Cumberland

Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.

2 months ago - Benzinga

Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q2 Earnings Expected to Decline

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Cumberland Pharmaceuticals To Announce Second Quarter 2021 Financial Results

NASHVILLE, Tenn., Aug. 3, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2021 financial results and provide a Company update afte...

2 months ago - PRNewsWire

Cumberland Pharmaceuticals Reports 2.5M Patient Doses Delivered, No Product Recalls, No FDA Issues in 2020

NASHVILLE, Tenn., July 26, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released its 2020 Sustainability Report, which details the compa...

2 months ago - PRNewsWire

John Rogers' Firm Makes Changes to Portfolio in June

John Rogers (Trades, Portfolio), leader of Ariel Investments, disclosed last week his firm made changes to its portfolio on June 30.

3 months ago - GuruFocus

4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness

4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness

Other symbols:ACERORGOXNCR
4 months ago - Zacks Investment Research

Vibativ® Effectively Helps Treat Secondary Bacterial Infections In COVID-19 Patients

NASHVILLE, Tenn., June 21, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness of...

4 months ago - PRNewsWire

Is Cumberland (CPIX) a Solid Growth Stock? 3 Reasons to Think " Yes "

Cumberland (CPIX) could produce exceptional returns because of its solid growth attributes.

4 months ago - Zacks Investment Research

Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer

NASHVILLE, Tenn., May 19, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has promoted John Hamm to  Director Finance & A...

5 months ago - PRNewsWire

Cumberland: Q1 Earnings Insights

Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 600.00% over the past year to $0.07, which b...

5 months ago - Benzinga

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update

NASHVILLE, Tenn., May 11, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial re...

5 months ago - PRNewsWire

Preview: Cumberland's Earnings

Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, May 11. Here is Benzinga's look at Cumberland's Q1 earnings report.

5 months ago - Benzinga

Cumberland Pharmaceuticals To Announce First Quarter 2021 Financial Results

NASHVILLE, Tenn., May 4, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2021 financial results and Company update after the market...

5 months ago - PRNewsWire

Providence's Tegria adds another company, acquires healthcare consulting firm Cumberland

Seattle-based Tegria, a healthcare services and tech company that Providence launched last year, announced the acquisition of Franklin, Tenn.

7 months ago - GeekWire

Cumberland Pharmaceuticals (CPIX) Beats Q4 Earnings and Revenue Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 200.00% and 4.93%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Recap: Cumberland Q4 Earnings

Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 88.89% over the past year to $0.01, which beat th...

7 months ago - Benzinga

Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020

NASHVILLE, Tenn., March 9, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, toda...

7 months ago - PRNewsWire

Cumberland Earnings Preview

Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's look at Cumberland's Q4 earnings report.

7 months ago - Benzinga

Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results

NASHVILLE, Tenn., March 2, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2020 financial results and Company update af...

7 months ago - PRNewsWire

Introducing RediTrex®, A New Methotrexate Delivery System

NASHVILLE, Tenn., Nov. 17, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company, announced today the launch of RediTrex® (methotrexate) injection....

11 months ago - PRNewsWire

Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q3 2020 Results - Earnings Call Transcript

Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q3 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Cumberland Pharmaceuticals (CPIX) Q3 Earnings and Revenues Surpass Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 128.57% and 7.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research